NASDAQ:DWTX | Cash Flow Statement | Dogwood Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$11.53M
2026-03-31-$4.99M-$4.59M$11.29M
2025-12-31-$3.78M-$3.64M$32,561.00
2025-09-30-$15.74M
2025-06-30-$3.81M
2025-03-31-$10.92M-$4.68M$7.37M
2024-12-31-$7.73M-$6.13M$15.32M
2024-09-30-$2.28M
2024-06-30-$1.05M
2024-03-31-$1.29M-$937,414.00
2023-12-31-$1.1M-$1.47M$0.00
2023-09-30-$1.24M
2023-06-30-$1.44M
2023-03-31-$1.52M-$1.7M
2022-12-31-$2.04M-$2.67M-$85,995.00
2022-09-30-$2.58M
2022-06-30-$3.67M
2022-03-31-$3.96M-$2.66M
2021-12-31-$4.51M-$5.18M$0.00
2021-09-30-$4.11M
2021-06-30-$4.28M
2021-03-31-$3.06M-$5.11M-$97,604.00
2020-12-31-$6.5M-$2.29M$31.58M
2020-09-30-$2.72M
2020-06-30-$654,585.00
2020-03-31-$466,553.00-$277,379.00$1.16M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$34.26M-$15.62M$7.28M
2024-12-31-$12.35M-$8.79M$3.76M$16.7M
2023-12-31-$5.3M-$4.87M$1.16M
2022-12-31-$12.25M-$11.47M$4.49M
2021-12-31-$15.96M-$15.69M-$97,604.00
2020-12-31-$10.35M-$3.9M$33.38M